These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6684921)

  • 1. The effect of dopamine on L-fucose incorporation into hippocampal and striatal slices of dopamine-supersensitive rats.
    Honza R; Jork R; Lössner B; Matthies H
    Biomed Biochim Acta; 1983; 42(4):419-22. PubMed ID: 6684921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine stimulated glycosylation of brain proteins in vitro is inhibited only partially by dopamine receptor antagonists.
    Lössner B; Jork R; Lindner M; Lucke B; Matthies H
    Biomed Biochim Acta; 1984; 43(6):775-87. PubMed ID: 6148936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-stimulated fucosylation of brain proteins in vitro is not inhibited by puromycin.
    Lössner B; Linke I; Eppendorfer B; Jork R
    Biomed Biochim Acta; 1985; 44(3):465-73. PubMed ID: 2988525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine stimulated fucosylation of rat hippocampal proteins in vitro. A histoautoradiographic study.
    Pohle W; Lössner B; Pchalek V
    Biomed Biochim Acta; 1985; 44(4):527-35. PubMed ID: 4026811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine stimulated L-fucose incorporation into brain proteins is related to an increase in fucokinase activity.
    Jork R; Schmitt M; Lössner B; Matthies H
    Biomed Biochim Acta; 1984; 43(3):261-70. PubMed ID: 6331424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine induced changes in L-fucose incorporation into proteins of rat hippocampus and corpus striatum during postnatal development.
    Lössner B; Jork R; Matthies H
    Pharmacol Biochem Behav; 1981 Nov; 15(5):705-9. PubMed ID: 6273939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAGE-autoradiography of fucose incorporation into rat hippocampal glycoproteins after acquisition of a brightness discrimination.
    Popov N; Pohle W; Schulzeck S; Matthies HK; Brödemann R; Matthies H
    Biomed Biochim Acta; 1983; 42(6):763-76. PubMed ID: 6639647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylglucamine orotate does not affect dopamine-stimulated fucosylation of rat hippocampal proteins.
    Pchalek V; Lössner B; Matthies H
    Biomed Biochim Acta; 1988; 47(9):843-8. PubMed ID: 3248122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dopamine-stimulated glycosylation of rat hippocampal proteins in vitro: structure-response relationship].
    Pchalek V; Lössner B; Matthies H
    Biomed Biochim Acta; 1985; 44(11-12):1651-8. PubMed ID: 4091838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of dopamine induced changes in hippocampal glycoprotein metabolism.
    Jork R; Schmidt S; Schulzeck S; Lössner B; Popov N; Matthies H
    Pharmacol Biochem Behav; 1982 Aug; 17(2):203-7. PubMed ID: 7134233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricularly applied D-galactosamine inhibits the incorporation of [(3)H]-fucose into rat brain glycoproteins.
    Popov N; Schulzeck S; Pohle W; Matthies H
    Acta Biol Med Ger; 1980; 39(1):13-20. PubMed ID: 7424331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    Sacaan AI; Dunlop JL; Lloyd GK
    J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH; Creese I; Burt DR
    Psychopharmacol Commun; 1975; 1(6):663-73. PubMed ID: 1241457
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine and macromolecule synthesis in rat hippocampus.
    Jork R; Lössner B; Matthies H
    Pharmacol Biochem Behav; 1979 Aug; 11(2):247-9. PubMed ID: 504305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the SNARE core complex by dopamine.
    Fisher H; Braun JE
    Can J Physiol Pharmacol; 2000 Oct; 78(10):856-9. PubMed ID: 11077986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of agents stimulating dopaminergic system on incorporation of exogenous adenine into striate body slices of the rat.
    Janiec W; Piekarska T; Pytlik M; Pałetko Z
    Pol J Pharmacol Pharm; 1978; 30(4):521-7. PubMed ID: 740554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-glutamate interaction in rat striatal slices: changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms.
    Tang FM; Sun YF; Wang R; Ding YM; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Feb; 21(2):145-50. PubMed ID: 11263261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The maintenance of hippocampal long-term potentiation is paralleled by a dopamine-dependent increase in glycoprotein fucosylation.
    Angenstein F; Matthies H; Staeck S; Reymann KG; Staak S
    Neurochem Int; 1992 Oct; 21(3):403-8. PubMed ID: 1338901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of dopamine receptors inhibited Ca2+-calmodulin-dependent protein kinase II activity in rat striatal slices.
    Hou XY; Tang FM; Zhang GY
    Acta Pharmacol Sin; 2001 Nov; 22(11):966-70. PubMed ID: 11749784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.